| Search for content and authors |
|
|
| |
 |
dr Monika Lamparska-Przybysz
|
| e-mail: | ***@celonpharma.com |
| phone: | |
| fax: | |
| web: | |
| interest(s): | |
|
Affiliation: |
Celon Pharma Ltd.
|
| address: | , Kiełpin, 05-092, Poland | | phone: | | | fax: | | | web: | | |
Participant: |
|
Participant: |
|
Publications: |
- CPL-200-075, a novel potent renal sodium-glucose cotransporter 2 (SGLT2) inhibitor
- Design and development of CPL-407-22 – novel, potent and selective JAK2 protein kinase inhibitor.
- Novel small molecule STAT3 inhibitors in cancer therapy.
- RNAi - breakthrough technology gives hope for breakthrough therapeutics
|
